SCOUT: Weight-Loss Drug Sibutramine Fails Safety Trial

STOCKHOLM (EGMN) – When European drug regulators called for a study to push the safety profile of the sympathomimetic weight-loss drug sibutramine to its limit, sibutramine failed the test.